Summarizing current variations in measurement of interval cancers rate and the potential differences in screening programmes, we will agree on definitions, calculation methodology and benchmark for interval cancer rate. Further, we will pilot data collection; produce report detailing purpose, methodology including international comparison, and develop mechanism for ongoing data collection and benchmarking.
This task will be led by DoH, Ireland and is co-led by ICO, Spain, UCY, Cyprus and HSE, Ireland.